12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Limaprost alfadex: Phase II started

Ono disclosed in its fiscal 1Q11 earnings ending June 30 that it started a double-blind, placebo-controlled, Japanese Phase II trial to evaluate Opalmon in about 150 patients. The...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >